⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CDTX News
Cidara Therapeutics, Inc.
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
prnewswire.com
EXAS
SEE
CDTX
MRSN
HAPPY THANKSGIVING AND EQUITY ALERT: The M&A Class Action Firm Launches Investigation for the Merger - EXAS, SEE, CDTX, and MRSN
accessnewswire.com
EXAS
SEE
CDTX
MRSN
Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Rights
globenewswire.com
AXTA
SEMR
CDTX
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
globenewswire.com
EXAS
SEE
CDTX
MRSN
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
globenewswire.com
CDTX
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-NUVSF, NDTAF, THS, and CDTX
prnewswire.com
THS
CDTX
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
RPTX
SEE
CDTX
MRSN
Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
CDTX
MRSN
HOLX
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
CDTX
CDTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Cidara Therapeutics, Inc. is Fair to Shareholders
businesswire.com
CDTX